TP53 and colorectal cancer: Some previous meta analysis show that, TP53 could be used as a biomarker for screening inflammatory bowel disease-related colorectal cancer and dysplasia (Du et al., 2017; Nakayama et al., 2017; Zhao et al., 2019).